Today: 17 May 2026
Oracle stock price today: ORCL heads into Tuesday reopen after 2.3% Friday rise as funding plan stays in focus
16 February 2026
1 min read

Oracle stock price today: ORCL heads into Tuesday reopen after 2.3% Friday rise as funding plan stays in focus

New York, Feb 16, 2026, 11:27 EST — The market has closed.

  • Oracle finished Friday at $160.14, gaining 2.34% on the day.
  • Presidents Day keeps U.S. markets closed Monday, with trading picking up again on Tuesday.
  • Oracle’s proposal to bankroll a hefty cloud expansion using a mix of debt and equity remains under scrutiny from investors.

Oracle finished Friday’s session 2.34% higher at $160.14. The software giant won’t resume trading until Tuesday, with the U.S. market closing for a holiday.

The timing’s notable: with U.S. markets closed for Presidents Day, trading won’t pick up again until Tuesday. Stocks and bonds both get a shortened week.

Oracle’s immediate outlook boils down to this: investors are grappling with how to value a major cloud expansion that needs significant capital, just as the wider market grows wary of hefty tech spending on artificial intelligence.

Oracle shares have pulled back hard from their 52-week peak at $345.72, as investors weigh rising Oracle Cloud Infrastructure revenues against the capital required to keep expansion going.

Oracle is targeting between $45 billion and $50 billion in new capital for 2026, aiming to boost its cloud infrastructure capacity. The company plans to tap both debt and equity markets to pull this off, it said earlier this month.

The company spelled out parts of its plan in a February 8-K, pointing to an “at-the-market” initiative that would let it sell as much as $20 billion in common stock gradually, plus a notes sale totaling $25 billion. SEC

Now, investors are zeroing in on Oracle’s ability to maintain solid cloud growth—enough to counterbalance dilution risks from stock sales and the drag of higher interest costs after taking on more debt. If AI-driven demand slows or customers push back workload plans, pressure could mount.

There’s the risk that the funding plan drags on the stock before any fresh revenue materializes, or that a steeper cost of capital squeezes Oracle’s balance sheet even more. Investors haven’t forgotten Oracle’s earnings miss and the company’s warning on increased spending back in December.

Oracle, for its part, is competing in a segment where giants—both hyperscalers and enterprise software players—are pouring billions into data centers and AI. That kind of arms race keeps investors jumpy about any hint that “build it and they will come” projections aren’t adding up.

U.S. markets are dark Monday, so the focus turns to Tuesday’s open and a busy macro calendar in the days ahead. Traders are zeroed in on what the Federal Reserve might signal about rates. Minutes from the Fed’s January 27-28 meeting are set for release Feb. 18, landing three weeks after the meeting itself.

Stock Market Today

  • Monster Beverage (MNST) Stock Near Fair Value After Multi-Year Gains
    May 16, 2026, 9:18 PM EDT. Monster Beverage (MNST) has delivered strong returns, rising nearly 89% over five years. The stock recently traded at around $87, modestly above its estimated intrinsic value of $80.02 based on a Discounted Cash Flow (DCF) model. This valuation approach projects Monster's free cash flow growing from $1.94 billion to over $3 billion by 2030. Despite impressive share price gains, the DCF suggests Monster is roughly 8.8% overvalued, indicating current prices are close to fair value rather than significantly overpriced. While the company's position in the US energy drink market supports growth prospects, its valuation score was 0 out of 6 on standard metrics, urging caution for new investors. Traders should monitor valuation shifts and market developments to time entries appropriately.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Micron stock price in focus as India start-up timeline lands on a US market holiday
Previous Story

Micron stock price in focus as India start-up timeline lands on a US market holiday

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Next Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Go toTop